Documents
Federal rules and notices from the public comment record, analyzed continuously.
FDA ▾
PSG_210134 - Draft Guidance on Glucagon
0 comments
Analysis in progress
Top issues in comments
PSG_212097 - Draft Guidance on Glucagon
0 comments
Analysis in progress
Top issues in comments
PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_214938 - Draft Guidance on Vosoritide
0 comments
Analysis in progress
Top issues in comments
PSG_215014 - Draft Guidance on Pegcetacoplan
0 comments
Analysis in progress
Top issues in comments
PSG_215256 - Draft Guidance on Semaglutide
0 comments
Analysis in progress
Top issues in comments
PSG_215866 - Draft Guidance on Tirzepatide
0 comments
Analysis in progress
Top issues in comments
PSG_217171 - Draft Guidance on Pegcetacoplan
0 comments
Analysis in progress
Top issues in comments
PSG_217806 - Draft Guidance on Tirzepatide
0 comments
Analysis in progress
Top issues in comments
Applying Human Factors and Usability Engineering to Medical Devices; Guidance for Industry and Food and Drug Administration Staff
0 comments
Analysis in progress
Top issues in comments
Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to an Ebola Disease Outbreak; Guidance for Industry
0 comments
Analysis in progress
Top issues in comments
Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs; Guidance for Industry; Final Guidance
0 comments
Analysis in progress
Top issues in comments